{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:06:20Z","timestamp":1765994780117,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"the Government of the Autonomous Province of Vojvodina, the Republic of Serbia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.transci.2020.103008","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T13:09:37Z","timestamp":1604668177000},"page":"103008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing donor suitability for blood donation: Utility of Geenius HIV 1\/2 confirmatory assay"],"prefix":"10.1016","volume":"60","author":[{"given":"Nevenka","family":"Bujandric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Grujic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorana","family":"Budakov Obradovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"Consolidated guidelines on HIV testing services. Annex 12. Comprehensive list of HTS approaches and considerations by epidemic setting","author":"WHO","key":"10.1016\/j.transci.2020.103008_bib0005"},{"year":"2012","series-title":"Blood donor selection: guidelines on assessing donor suitability for blood donation","key":"10.1016\/j.transci.2020.103008_bib0010"},{"issue":"6","key":"10.1016\/j.transci.2020.103008_bib0015","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/trf.15245","article-title":"HIV-1\/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferral","volume":"59","author":"Stoyanov","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.103008_bib0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/QAI.0000000000001146","article-title":"Performance of the Bio-Rad Geenius HIV1\/2 Supplemental Assay in detecting \u201crecent\u201d HIV infection an calculating population incidence","volume":"73","author":"Keating","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.transci.2020.103008_bib0025","first-page":"173","article-title":"Laboratory and epidemiology communications examination of efficient HIV confirmatory testing protocols using an HIV-1\/2 antibody differentiation assay jpn","volume":"73","author":"Nagashima","year":"2020","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.transci.2020.103008_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25018","article-title":"Assays for estimating HIV incidence: updated global market assessment and estimated economic value","volume":"20","author":"Morrison","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.transci.2020.103008_bib0035","series-title":"HIV and the blood supply: an analysis of crisis decisionmaking","first-page":"5","article-title":"Institute of medicine (US) committee to study HIV transmission through blood and blood products","year":"1995"},{"issue":"6","key":"10.1016\/j.transci.2020.103008_bib0040","doi-asserted-by":"crossref","first-page":"e01398","DOI":"10.1128\/JCM.01398-18","article-title":"Evaluation of the bio-rad geenius HIV 1\/2 assay as part of a confirmatory HIV testing strategy for Quebec, Canada: comparison with western blot and inno-lia assays","volume":"57","author":"Serhir","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.transci.2020.103008_bib0045","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jmv.24490","article-title":"High rate of missed HIV infections in individuals with indeterminate or negative HIV western blots based on current HIV testing algorithm in China","volume":"88","author":"Liu","year":"2016","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2020.103008_bib0050","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3389\/fmicb.2019.01322","article-title":"Estimation of the seroconversion duration of HIV-1 antibodies in individuals with recent infection in China","volume":"10","author":"Kong","year":"2019","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.transci.2020.103008_bib0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1017\/S0950268816002910","article-title":"Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead","volume":"145","author":"Murphy","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.transci.2020.103008_bib0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/QAD.0000000000002190","article-title":"Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results","volume":"33","author":"Pilcher","year":"2019","journal-title":"AIDS"},{"year":"2018","series-title":"2018 Quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens","author":"Centers for Disease Control and Prevention and Association of Public Health Laboratories","key":"10.1016\/j.transci.2020.103008_bib0065"},{"key":"10.1016\/j.transci.2020.103008_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2017.08.003","article-title":"Staging of recent HIV-1 infection using Geenius rapid confirmatory assay compared to INNO-LIA, New Lav and Blot 2.2 assays","volume":"95","author":"Tuaillon","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.transci.2020.103008_bib0075","doi-asserted-by":"crossref","first-page":"P71","DOI":"10.1186\/1471-2334-14-S2-P71","article-title":"Evaluation of the Bio-Rad Geenius HIV-1\/2 test as a confirmatory assay","volume":"14","author":"Montesinos","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.transci.2020.103008_bib0080","doi-asserted-by":"crossref","first-page":"e0139169","DOI":"10.1371\/journal.pone.0139169","article-title":"Evaluation of the bio-rad geenius HIV 1\/2 confirmation assay as an alternative to western blot in the korean population: a multi-center study","volume":"10","author":"Moon","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.transci.2020.103008_bib0085","doi-asserted-by":"crossref","first-page":"e0198924","DOI":"10.1371\/journal.pone.0198924","article-title":"Comparative evaluation of the geenius HIV 1\/2 confirmatory assay and the HIV-1 and HIV-2 western blots in the japanese population","volume":"13","author":"Kondo","year":"2018","journal-title":"PLoS One"},{"issue":"91","key":"10.1016\/j.transci.2020.103008_bib0090","article-title":"Evaluation of two HIV antibody confirmatory assays: Geenius\u2122 HIV1\/2 Confirmatory Assay and the recomLine HIV-1 & HIV-2 IgG Line Immunoassay","volume":"224","author":"Friedrichs","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.transci.2020.103008_bib0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcv.2017.04.005","article-title":"Comparative performance of the Geenius\u2122 HIV-1\/HI-2 supplemental test in Florida\u2019s public health testing population","volume":"91","author":"Fordan","year":"2017","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.transci.2020.103008_bib0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-015-0086-3","article-title":"Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests","volume":"13","author":"Liu","year":"2016","journal-title":"AIDS Res Ther"},{"issue":"9","key":"10.1016\/j.transci.2020.103008_bib0105","article-title":"Repeated false reactive ADVIA centaur\u00ae and bio-rad Geenius\u2122 HIV tests in a patient self-administering anabolic steroids","volume":"20","author":"Tsybina","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.transci.2020.103008_bib0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12250-019-00130-3","article-title":"Prevalence of HIV indeterminate western blot tests and follow-up of HIV antibody sero-conversion in Southeastern China","volume":"34","author":"Wu","year":"2019","journal-title":"Virol Sin"},{"key":"10.1016\/j.transci.2020.103008_bib0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcv.2018.12.006","article-title":"Performance evaluation of the Bio-Rad Geenius HIV 1\/2 supplemental assay","volume":"111","author":"Luo","year":"2019","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.transci.2020.103008_bib0120","doi-asserted-by":"crossref","first-page":"e0199502","DOI":"10.1371\/journal.pone.0199502","article-title":"Performance of the HIV blot 2.2, INNO-LIA HIV I\/II score, and geenius HIV 1\/2 confirmatory assay for use in HIV confirmation","volume":"13","author":"Wong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2020.103008_bib0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcv.2014.12.018","article-title":"HIV-1 infection using dried blood spots can be confirmed by Bio-Rad Geenius\u2122 HIV 1\/2 confirmatory assay","volume":"63","author":"Fern\u00e1ndez McPhee","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.transci.2020.103008_bib0130","doi-asserted-by":"crossref","DOI":"10.1111\/trf.15819","article-title":"Qualification of the Geenius HIV 1\/2 supplemental assay for use in the HIV blood donation screening algorithm","author":"Sa\u00e1","year":"2020","journal-title":"Transfusion"},{"issue":"24","key":"10.1016\/j.transci.2020.103008_bib0135","doi-asserted-by":"crossref","first-page":"94355","DOI":"10.1172\/jci.insight.94355","article-title":"Computational analysis of antibody dynamics identifies recent HIV-1 infection","volume":"2","author":"Seaton","year":"2017","journal-title":"JCI Insight"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220303311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220303311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:59Z","timestamp":1761468719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220303311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1473050220303311"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.103008","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing donor suitability for blood donation: Utility of Geenius HIV 1\/2 confirmatory assay","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.103008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103008"}}